Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for Attention-Deficit/Hyperactivity Disorder

Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for... ORIGINAL ARTICLE Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for Attention-Deficit/Hyperactivity Disorder Kurt P. Schulz, PhD; Jin Fan, PhD; Anne-Claude V. Be´dard, PhD; Suzanne M. Clerkin, PhD; Iliyan Ivanov, MD; Cheuk Y. Tang, PhD; Jeffrey M. Halperin, PhD; Jeffrey H. Newcorn, MD Context: Attention-deficit/hyperactivity disorder (ADHD) vestigator-completed ratings on the ADHD Rating Scale- is a highly prevalent and impairing psychiatric disorder IV-Parent Version. that affects both children and adults. There are Food and Drug Administration–approved stimulant and nonstimu- Results: Treatment with methylphenidate vs atomox- lant medications for treating ADHD; however, little is etine was associated with comparable improvements in both known about the mechanisms by which these different response inhibition on the go/no-go test and mean (SD) treatments exert their therapeutic effects. improvements in ratings of ADHD symptoms (55% [30%] vs 57% [25%]). Improvement in ADHD symptoms was as- Objective: To contrast changes in brain activation re- sociated with common reductions in bilateral motor cor- lated to symptomatic improvement with use of the stimu- tex activation for both treatments. Symptomatic improve- lant methylphenidate hydrochloride vs the nonstimu- ment was also differentially related to gains in task-related lant atomoxetine hydrochloride. activation for atomoxetine and reductions in activation http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Psychiatry American Medical Association

Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for Attention-Deficit/Hyperactivity Disorder

Loading next page...
 
/lp/american-medical-association/common-and-unique-therapeutic-mechanisms-of-stimulant-and-nonstimulant-pBvhcDUMYF
Publisher
American Medical Association
Copyright
Copyright 2012 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-622X
eISSN
2168-6238
DOI
10.1001/archgenpsychiatry.2011.2053
pmid
22945622
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for Attention-Deficit/Hyperactivity Disorder Kurt P. Schulz, PhD; Jin Fan, PhD; Anne-Claude V. Be´dard, PhD; Suzanne M. Clerkin, PhD; Iliyan Ivanov, MD; Cheuk Y. Tang, PhD; Jeffrey M. Halperin, PhD; Jeffrey H. Newcorn, MD Context: Attention-deficit/hyperactivity disorder (ADHD) vestigator-completed ratings on the ADHD Rating Scale- is a highly prevalent and impairing psychiatric disorder IV-Parent Version. that affects both children and adults. There are Food and Drug Administration–approved stimulant and nonstimu- Results: Treatment with methylphenidate vs atomox- lant medications for treating ADHD; however, little is etine was associated with comparable improvements in both known about the mechanisms by which these different response inhibition on the go/no-go test and mean (SD) treatments exert their therapeutic effects. improvements in ratings of ADHD symptoms (55% [30%] vs 57% [25%]). Improvement in ADHD symptoms was as- Objective: To contrast changes in brain activation re- sociated with common reductions in bilateral motor cor- lated to symptomatic improvement with use of the stimu- tex activation for both treatments. Symptomatic improve- lant methylphenidate hydrochloride vs the nonstimu- ment was also differentially related to gains in task-related lant atomoxetine hydrochloride. activation for atomoxetine and reductions in activation

Journal

JAMA PsychiatryAmerican Medical Association

Published: Sep 1, 2012

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month